Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CANB

Can B (CANB) Stock Price, News & Analysis

Can B logo

About Can B Stock (NASDAQ:CANB)

Advanced Chart

Key Stats

Today's Range
$0.06
$0.07
50-Day Range
$0.37
$8.24
52-Week Range
$0.27
$1.05
Volume
225,035 shs
Average Volume
189,959 shs
Market Capitalization
$5.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Can B Corp. engages in the development, production, and sale of products and delivery devices containing cannabidiol. Its product portfolio includes hemp extract oils and sprays, pain and skin care, softgels and capsules, superfoods, supplements, bath and spa, and pets. The company was founded by Rolv Eitrem Heggenhougen and Romuald Stone on October 11, 2005 and is headquartered in Hicksville, NY.

Receive CANB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Can B and its competitors with MarketBeat's FREE daily newsletter.

CANB Stock News Headlines

Trump’s tariffs just split the AI market in two
Trump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying on cheap foreign hardware—just saw their costs shoot through the roof. For the other group of AI companies, they were just handed a massive competitive advantage. Make no mistake, AI as a whole is still a game-changer for the global economy. But within the AI sector, Trump’s tariffs have created a huge divergence.
See More Headlines

CANB Stock Analysis - Frequently Asked Questions

Can B (CANB) raised $10 million in an initial public offering (IPO) on Tuesday, August 9th 2022. The company issued 2,000,000 shares at a price of $5.05 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Can B investors own include Fulcrum Therapeutics (FULC), Actinium Pharmaceuticals (ATNM), Provention Bio (PRVB), VIVUS (VVUS), Chimerix (CMRX), OpGen (OPGN) and Processa Pharmaceuticals (PCSA).

Company Calendar

Today
4/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:CANB
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,740,000.00
Net Margins
-1,238.33%
Pretax Margin
-1,351.68%

Debt

Sales & Book Value

Annual Sales
$2.16 million
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-0.22

Miscellaneous

Free Float
74,137,000
Market Cap
$5.04 million
Optionable
Not Optionable
Beta
1.46
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CANB) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners